Brighter signs 5-year agreement and receives initial order for Actiste® worth EUR 2.3 Million in Nigeria
Brighter AB (publ) (“The company” or “Brighter”) has signed a five-year distribution agreement with Wssonlines Nigeria Ltd in Nigeria (“the Distributor”) regarding Brighter’s pioneering product portfolio for diabetes management, Actiste® (“Actiste® Service”). Both Actiste® and the newly developed Actiste® Mini are included in the agreement. The agreed minimum order volume for the first 12 months of the five-year agreement amounts to 8,000 subscriptions, corresponding to an estimated revenue of c. EUR 6.3 million. The exact amount depends on the final distribution between Actiste® and